HuGE Literature Finder
Records
1
-
30
| Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 1 JCO2201239. Yadav Siddhartha, Boddicker Nicholas J, Na Jie, Polley Eric C, Hu Chunling, Hart Steven N, Gnanaolivu Rohan D, Larson Nicole, Holtegaard Susan, Huang Huaizhi, Dunn Carolyn A, Teras Lauren R, Patel Alpa V, Lacey James V, Neuhausen Susan L, Martinez Elena, Haiman Christopher, Chen Fei, Ruddy Kathryn J, Olson Janet E, John Esther M, Kurian Allison W, Sandler Dale P, O'Brien Katie M, Taylor Jack A, Weinberg Clarice R, Anton-Culver Hoda, Ziogas Argyrios, Zirpoli Gary, Goldgar David E, Palmer Julie R, Domchek Susan M, Weitzel Jeffrey N, Nathanson Katherine L, Kraft Peter, Couch Fergus |
| Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study. Breast cancer (Tokyo, Japan) 2023 3 . Kikuchi Mari, Gomi Naoya, Ueki Arisa, Osako Tomo, Terauchi Takas |
| Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. Genes 2023 1 14 (1): . Nassar Auhood, Zekri Abdel-Rahman N, Kamel Mahmoud M, Elberry Mostafa H, Lotfy Mai M, Seadawy Mohamed G, Hassan Zeinab K, Soliman Hany K, Lymona Ahmed M, Youssef Amira Salah El-D |
| Genetic, Surgical and Oncological Approach to Breast Cancer, with BRCA1, BRCA2, CDH1, PALB2, PTEN and TP53 Variants. European journal of breast health 2023 1 19 (1): 55-69. Suba??o?lu Asl?, Güç Zeynep Gülsüm, Gür Emine Özlem, Tekindal Mustafa Agah, Atahan Murat Kem |
| Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer. Breast cancer (Dove Medical Press) 2023 1 15 1-10. Abdel-Razeq Hikmat, Abujamous Lama, Al-Azzam Khansa, Abu-Fares Hala, Bani Hani Hira, Alkyam Mais, Sharaf Baha', Elemian Shatha, Tamimi Faris, Abuhijla Fawzi, Edaily Sarah, Salama Osama, Abdulelah Hazem, Daoud Rand, Abubaker Mohammad, Al-Atary Are |
| Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation. Cancer 2023 1 129 (6): 845-859. Jin Juan, Cao Jianing, Li Bin, Li Ting, Zhang Jian, Cao Jun, Zhao Mingchun, Wang Leiping, Wang Biyun, Tao Zhonghua, Hu Xich |
| Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations. Human genomics 2023 1 17 (1): 2. Kim Jinyong, Jeong Kyeonghun, Jun Hyeji, Kim Kwangsoo, Bae Jeong Mo, Song Myung Geun, Yi Hanbaek, Park Songyi, Woo Go-Un, Lee Dae-Won, Kim Tae-Yong, Lee Kyung-Hun, Im Seock- |
| Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment 2023 3 . Bychkovsky Brittany L, Lo Min-Tzu, Yussuf Amal, Horton Carrie, Hemyari Parichehr, LaDuca Holly, Garber Judy E, Scheib Rochelle, Rana Huma |
| Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand. Asian Pacific journal of cancer prevention : APJCP 2023 2 24 (2): 525-530. Sukpan Panupong, Kanokwiroon Kanyanatt, Sriplung Hutcha, Laochareonsuk Wison, Choochuen Pongsakorn, Auseng Nasuha, Wanawanakorn Kasemsun, Sangkhathat Suras |
| The Contribution of Germline Pathogenic Variants in Breast Cancer Genes to Contralateral Breast Cancer Risk in BRCA1/BRCA2/PALB2-Negative Women. Cancers 2023 1 15 (2): . Larionov Alexey, Fewings Eleanor, Redman James, Goldgraben Mae, Clark Graeme, Boice John, Concannon Patrick, Bernstein Jonine, Conti David V, The Wecare Study Collaborative Group , Tischkowitz Ma |
| The impact of coding germline variants on contralateral breast cancer risk and survival. American journal of human genetics 2023 2 110 (3): 475-486. Morra Anna, Mavaddat Nasim, Muranen Taru A, Ahearn Thomas U, Allen Jamie, Andrulis Irene L, Auvinen Päivi, Becher Heiko, Behrens Sabine, Blomqvist Carl, Bojesen Stig E, Bolla Manjeet K, Brauch Hiltrud, Camp Nicola J, Carvalho Sara, Castelao Jose E, Cessna Melissa H, Chang-Claude Jenny, Chenevix-Trench Georgia, , Czene Kamila, Decker Brennan, Dennis Joe, Dörk Thilo, Dorling Leila, Dunning Alison M, Ekici Arif B, Eriksson Mikael, Evans D Gareth, Fasching Peter A, Figueroa Jonine D, Flyger Henrik, Gago-Dominguez Manuela, García-Closas Montserrat, Geurts-Giele Willemina R R, Giles Graham G, Guénel Pascal, Gündert Melanie, Hahnen Eric, Hall Per, Hamann Ute, Harrington Patricia A, He Wei, Heikkilä Päivi, Hooning Maartje J, Hoppe Reiner, Howell Anthony, Humphreys Keith, , Jakubowska Anna, Jung Audrey Y, Keeman Renske, Kristensen Vessela N, Lubi?ski Jan, Mannermaa Arto, Manoochehri Mehdi, Manoukian Siranoush, Margolin Sara, Mavroudis Dimitrios, Milne Roger L, Mulligan Anna Marie, Newman William G, Park-Simon Tjoung-Won, Peterlongo Paolo, Pharoah Paul D P, Rhenius Valerie, Saloustros Emmanouil, Sawyer Elinor J, Schmutzler Rita K, Shah Mitul, Spurdle Amanda B, Tomlinson Ian, Truong Thérèse, van Veen Elke M, Vreeswijk Maaike P G, Wang Qin, Wendt Camilla, Yang Xiaohong R, Nevanlinna Heli, Devilee Peter, Easton Douglas F, Schmidt Marjanka |
| Whole exome sequencing and replication for breast cancer among Hispanic/Latino women identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer. medRxiv : the preprint server for health sciences 2023 2 . Nierenberg Jovia L, Adamson Aaron W, Hu Donglei, Huntsman Scott, Patrick Carmina, Li Min, Steele Linda, Tong Barry, Shieh Yiwey, Fejerman Laura, Gruber Stephen B, Haiman Christopher A, John Esther M, Kushi Lawrence H, Torres-Mejía Gabriela, Ricker Charité, Weitzel Jeffrey N, Ziv Elad, Neuhausen Susan |
| Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes. Annals of oncology : official journal of the European Society for Medical Oncology 2022 Sep . Loveday C, Garrett A, Law P, Hanks S, Poyastro-Pearson E, Adlard J W, Barwell J, Berg J, Brady A F, Brewer C, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison P J, Paterson J, Porteous M, Rogers M T, Walker L, , Eccles D, Evans D G, Snape K, Hanson H, Houlston R S, Turnbull |
| Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan. HPB : the official journal of the International Hepato Pancreato Biliary Association 2022 Sep . Muhammad Noor, Sadaqat Rida, Naeemi Humaira, Masood Iqra, Hassan Usman, Ijaz Bushra, Hanif Faisal, Syed Aamir A, Yusuf Muhammed A, Rashid Muhammad |
| Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study. International journal of molecular sciences 2022 Sep 23 (19): . Yang Liu, Xie Fei, Liu Chang, Zhao Jin, Hu Taobo, Wu Jinbo, Zhao Xiaotao, Wang S |
| A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies. Environmental and molecular mutagenesis 2022 Jul 63 (6): 308-316. Shao Changxia, Wan Jun, Lam Fred C, Tang Huilin, Marley Andrew R, Song Yiqing, Miller Chelsey, Brown Madeline, Han Jiali, Adeboyeje Gboye |
| [Oncogénétique dans les cancers de l'ovaire]. La Revue du praticien 2022 7 72 (6): 639-641. Desseignés Camille, Benusiglio Patri |
| A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes. Nature cancer 2022 10 3 (10): 1181-1191. Gruber Joshua J, Afghahi Anosheh, Timms Kirsten, DeWees Alyssa, Gross Wyatt, Aushev Vasily N, Wu Hsin-Ta, Balcioglu Mustafa, Sethi Himanshu, Scott Danika, Foran Jessica, McMillan Alex, Ford James M, Telli Melinda |
| Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease. European journal of cancer (Oxford, England : 1990) 2022 12 179 76-86. Jiao Yue, Truong Thérèse, Eon-Marchais Séverine, Mebirouk Noura, Caputo Sandrine M, Dondon Marie-Gabrielle, Karimi Mojgan, Le Gal Dorothée, Beauvallet Juana, Le Floch Édith, Dandine-Roulland Claire, Bacq-Daian Delphine, Olaso Robert, Albuisson Juliette, Audebert-Bellanger Séverine, Berthet Pascaline, Bonadona Valérie, Buecher Bruno, Caron Olivier, Cavaillé Mathias, Chiesa Jean, Colas Chrystelle, Collonge-Rame Marie-Agnès, Coupier Isabelle, Delnatte Capucine, De Pauw Antoine, Dreyfus Hélène, Fert-Ferrer Sandra, Gauthier-Villars Marion, Gesta Paul, Giraud Sophie, Gladieff Laurence, Golmard Lisa, Lasset Christine, Lejeune-Dumoulin Sophie, Léoné Mélanie, Limacher Jean-Marc, Lortholary Alain, Luporsi Élisabeth, Mari Véronique, Maugard Christine M, Mortemousque Isabelle, Mouret-Fourme Emmanuelle, Nambot Sophie, Noguès Catherine, Popovici Cornel, Prieur Fabienne, Pujol Pascal, Sevenet Nicolas, Sobol Hagay, Toulas Christine, Uhrhammer Nancy, Vaur Dominique, Venat Laurence, Boland-Augé Anne, Guénel Pascal, Deleuze Jean-François, Stoppa-Lyonnet Dominique, Andrieu Nadine, Lesueur Fabien |
| Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. Frontiers in oncology 2022 12 976959. Paixão Daniele, Torrezan Giovana Tardin, Santiago Karina Miranda, Formiga Maria Nirvana, Ahuno Samuel Terkper, Dias-Neto Emmanuel, Tojal da Silva Israel, Foulkes William D, Polak Paz, Carraro Dirce Mar |
| Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases. Journal of medical genetics 2022 9 . Lakeman Inge M M, Rodríguez-Girondo Mar D M, Lee Andrew, Celosse Nandi, Braspenning Merel E, van Engelen Klaartje, van de Beek Irma, van der Hout Annemiek H, Gómez García Encarna B, Mensenkamp Arjen R, Ausems Margreet G E M, Hooning Maartje J, Adank Muriel A, Hollestelle Antoinette, Schmidt Marjanka K, van Asperen Christi J, Devilee Pet |
| Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022 9 . Lucas Aimee L, Fu Yichun, Labiner Arielle J, Dimaio Christopher J, Sethi Amrita, Kastrinos F |
| Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2. NPJ breast cancer 2022 7 8 (1): 86. Wu Shijie, Qi Lina, Chen Huihui, Zhang Kun, He Jiapan, Guo Xianan, Shen Lu, Zhou Yunxiang, Zhong Xi, Zheng Shu, Zhou Jiaojiao, Chen Yidi |
| Hereditary Breast Cancer in the Brazilian State of Ceará (The CHANCE Cohort): Higher-Than-Expected Prevalence of Recurrent Germline Pathogenic Variants. Frontiers in oncology 2022 12 932957. Gifoni Ana Carolina Leite Vieira Costa, Gifoni Markus Andret Cavalcante, Wotroba Camila Martins, Palmero Edenir Inez, Costa Eduardo Leite Vieira, Dos Santos Wellington, Achatz Maria Isab |
| Influence of germline test results on surgical decision making in women with invasive breast cancer. Cancer genetics 2022 7 266-267 81-85. Vargason Ashlee B, Turner Clesson E, Shriver Craig D, Ellsworth Rachel |
| Multi-gene panel testing increases germline predisposing mutations' detection in a cohort of breast/ovarian cancer patients from Southern Italy. Frontiers in medicine 2022 9 894358. Nunziato Marcella, Di Maggio Federica, Pensabene Matilde, Esposito Maria Valeria, Starnone Flavio, De Angelis Carmine, Calabrese Alessandra, D'Aiuto Massimiliano, Botti Gerardo, De Placido Sabino, D'Argenio Valeria, Salvatore Frances |
| Pathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin. Asian Pacific journal of cancer prevention : APJCP 2022 6 23 (6): 2027-2033. Gervas Polina, Molokov Aleksey, Babyshkina Nataliya, Kiselev Artem, Zarubin Aleksei, Yumov Evgeny, Pisareva Lubov, Choynzonov Evgeny, Cherdyntseva Nadez |
| Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancers 2022 7 14 (13): . Rolfes Muriel, Borde Julika, Möllenhoff Kathrin, Kayali Mohamad, Ernst Corinna, Gehrig Andrea, Sutter Christian, Ramser Juliane, Niederacher Dieter, Horváth Judit, Arnold Norbert, Meindl Alfons, Auber Bernd, Rump Andreas, Wang-Gohrke Shan, Ritter Julia, Hentschel Julia, Thiele Holger, Altmüller Janine, Nürnberg Peter, Rhiem Kerstin, Engel Christoph, Wappenschmidt Barbara, Schmutzler Rita K, Hahnen Eric, Hauke J |
| Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants. Journal of the National Cancer Institute 2022 10 115 (2): 181-189. Lim Belle W X, Li Na, Mahale Sakshi, McInerny Simone, Zethoven Magnus, Rowley Simone M, Huynh Joanne, Wang Theresa, Lee Jue Er Amanda, Friedman Mia, Devereux Lisa, Scott Rodney J, Sloan Erica K, James Paul A, Campbell Ian |
| Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer. Cancer medicine 2022 8 . Sokolenko Anna P, Sultanova Luisa V, Stepanov Ilya A, Romanko Alexandr A, Venina Aigul R, Sokolova Tatiana N, Musayeva Hedi S, Tovgereeva Marina Ya, Magomedova Mareta Kh, Akhmatkhanov Khusein U, Vagapova Elisa I, Suleymanov Elkhan A, Vasilyeva Elena V, Bakaeva Elvina Kh, Bizin Ilya V, Aleksakhina Svetlana N, Imyanitov Evgeny |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: